Year archive

Telix Pharmaceuticals Ltd — 2024 filings

All 164 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2024, sourced directly from the official regulator.

164 Filings

2024 Period

2024 filings (164)

Filing	Released	Lang
CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS Regulatory Filings	2024-12-30	English
Telix Files TLX250-CDx (Zircaix) BLA for Kidney Imaging 2 pages 151.0KB Regulatory Filings	2024-12-29	English
Managing Director and Group CEO Remuneration Update 3 pages 151.3KB Remuneration Information	2024-12-29	English
S-8 Regulatory Filings	2024-12-19	English
Securities Dealing Policy - Updated 13 pages 317.2KB Regulatory Filings	2024-12-12	English
Application for quotation of securities - TLX 6 pages 18.6KB Share Issue/Capital Change	2024-11-27	English
Notification regarding unquoted securities - TLX 8 pages 27.9KB Share Issue/Capital Change	2024-11-27	English
Regulatory Filings 2024 Regulatory Filings	2024-11-21	English
6-K Regulatory Filings	2024-11-19	English
Telix Adds FAP-Targeting Theranostic Candidates to Pipeline 3 pages 151.0KB Capital/Financing Update	2024-11-18	English
Presentation to Accompany FAP-Targeting Acquisition 14 pages 1.5MB Investor Presentation	2024-11-18	English
6-K Regulatory Filings	2024-11-14	English
Telix ADSs Commence Trading on Nasdaq 2 pages 130.7KB Capital/Financing Update	2024-11-13	English
Securities Dealing Policy - Updated 11 pages 304.2KB Regulatory Filings	2024-11-13	English
Regulatory Filings 2024 Regulatory Filings	2024-11-13	English
Regulatory Filings 2024 Regulatory Filings	2024-11-12	English
Regulatory Filings 2024 Regulatory Filings	2024-11-12	English
Regulatory Filings 2024 Regulatory Filings	2024-11-12	English
CMS payment improvement decision for radiopharma diagnostics 3 pages 155.2KB Regulatory Filings	2024-11-03	English
Regulatory Filings 2024 Regulatory Filings	2024-10-30	English
20FR12B/A Annual Report	2024-10-30	English
FDA accepts NDA and grants priority review for Pixclara 3 pages 164.4KB Regulatory Filings	2024-10-23	English
Pending Release of Shares from Voluntary Escrow 2 pages 149.7KB Regulatory Filings	2024-10-22	English
Regulatory Filings 2024 Regulatory Filings	2024-10-17	English
Regulatory Filings 2024 Regulatory Filings	2024-10-17	English
20FR12B Annual Report	2024-10-17	English
Telix Files Form 20-F Registration Statement for Nasdaq ADS 2 pages 183.7KB Capital/Financing Update	2024-10-17	English
Telix Q3 2024 Revenue and Business Update 5 pages 275.1KB Earnings Release Q3 2024	2024-10-16	English
Andreas Kluge to Retire from Telix Board 2 pages 137.0KB Board/Management Information	2024-10-16	English
Appendix 3Z Final Director Notice (A Kluge) 2 pages 242.7KB Director's Dealing	2024-10-16	English
Regulatory Filings 2024 Regulatory Filings	2024-10-10	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-10-07	English
Notification of cessation of securities - TLX 5 pages 18.1KB Major Shareholding Notification	2024-10-07	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-09-25	English
Telix to Acquire RLS for US Manufacturing and Distribution 3 pages 160.0KB M&A Activity	2024-09-22	English
Annual Report 2024 Annual Report	2024-09-13	English
Notification regarding unquoted securities - TLX 7 pages 23.1KB Share Issue/Capital Change	2024-09-10	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-09-08	English
Becoming a substantial holder 47 pages 4.7MB Major Shareholding Notification	2024-08-29	English
Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent 3 pages 163.6KB Regulatory Filings	2024-08-27	English
Telix Reorganisation to Deliver on Strategic Priorities 2 pages 154.7KB Board/Management Information	2024-08-26	English
Telix 1H 2024 Appendix 4D and Interim Report 49 pages 6.5MB Interim / Quarterly Report H1 2024	2024-08-21	English
Telix 1H 2024 Results Release 3 pages 133.0KB Interim / Quarterly Report H1 2024	2024-08-21	English
Telix 1H 2024 Results Presentation 24 pages 1.3MB Investor Presentation	2024-08-21	English
Securities Dealing Policy - Updated 11 pages 272.3KB Regulatory Filings	2024-08-21	English
Ceasing to be a substantial holder 4 pages 479.7KB Major Shareholding Notification	2024-08-21	English
Becoming a substantial holder 46 pages 4.7MB Major Shareholding Notification	2024-08-20	English
Ceasing to be a substantial holder 4 pages 496.5KB Major Shareholding Notification	2024-08-13	English
Becoming a substantial holder 40 pages 4.1MB Major Shareholding Notification	2024-08-12	English
Telix 2024 Half-Year Results Investor Webcast Notification 2 pages 138.2KB Report Publication Announcement	2024-08-12	English
Ceasing to be a substantial holder 6 pages 630.9KB Major Shareholding Notification	2024-08-06	English
Ceasing to be a substantial holder 22 pages 2.1MB Major Shareholding Notification	2024-08-04	English
BLA Filing Update for Renal Cancer Imaging Agent TLX250-CDx 3 pages 156.0KB Regulatory Filings	2024-07-30	English
Investor Conference Call - TLX250-CDx BLA Filing Update 2 pages 139.3KB Regulatory Filings	2024-07-30	English
Convertible Bond Cleansing Notice 283 pages 2.9MB Capital/Financing Update	2024-07-29	English
Telix Completes A$650 Million of Convertible Bonds 1 Capital/Financing Update	2024-07-29	English
Appendix 3G 18 pages 413.6KB Share Issue/Capital Change	2024-07-29	English
Becoming a substantial holder 39 pages 1.8MB Major Shareholding Notification	2024-07-28	English
Becoming a substantial holder 34 pages 3.3MB Major Shareholding Notification	2024-07-25	English
Telix Successfully Prices A$650M Convertible Bonds 3 pages 153.5KB Capital/Financing Update	2024-07-23	English
Appendix 3B 55 pages 1.1MB Capital/Financing Update	2024-07-23	English
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 2 pages 148.3KB Regulatory Filings	2024-07-23	English
Telix Announces A$600 Million Convertible Bonds Offering 3 pages 161.4KB Capital/Financing Update	2024-07-22	English
Telix Investor Presentation July 2024 24 pages 1.9MB Investor Presentation	2024-07-22	English
Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade 4 pages 222.6KB Capital/Financing Update	2024-07-17	English
CMS proposes payment improvement for radiopharma diagnostics 2 pages 145.1KB Regulatory Filings	2024-07-10	English
Notification of cessation of securities - TLX 4 pages 15.5KB Transaction in Own Shares	2024-07-09	English
Application for quotation of securities - TLX 6 pages 18.7KB Share Issue/Capital Change	2024-07-03	English
Cleansing Notice 1 page 117.0KB Capital/Financing Update	2024-07-03	English
Pending Release of Shares from Voluntary Escrow 2 pages 148.7KB Regulatory Filings	2024-07-02	English
Ceasing to be a substantial holder from MUFG 627 pages 3.2MB Major Shareholding Notification	2024-07-02	English
Ceasing to be a substantial holder 2 pages 482.9KB Major Shareholding Notification	2024-07-02	English
Ceasing to be a substantial holder 4 pages 798.3KB Major Shareholding Notification	2024-07-01	English
Ceasing to be a substantial holder from MS 180 pages 930.3KB Major Shareholding Notification	2024-07-01	English
Ceasing to be a substantial holder 2 pages 192.8KB Major Shareholding Notification	2024-07-01	English
Ceasing to be a substantial holder 2 pages 182.0KB Major Shareholding Notification	2024-07-01	English
Notification regarding unquoted securities - TLX 6 pages 20.3KB Share Issue/Capital Change	2024-06-26	English
Appendix 3Y Change in Director Interests - C Behrenbruch 4 pages 347.4KB Director's Dealing	2024-06-26	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-06-26	English
Cleansing Notice 1 page 149.2KB Capital/Financing Update	2024-06-26	English
RW Regulatory Filings	2024-06-14	English
RW Regulatory Filings	2024-06-14	English
Telix Elects to Withdraw from Proposed U.S. Listing 2 pages 147.7KB Capital/Financing Update	2024-06-13	English
Trading Halt 2 pages 495.2KB Capital/Financing Update	2024-06-12	English
8-A12B Regulatory Filings	2024-06-10	English
Telix Launches Proposed US IPO 2 pages 141.5KB Capital/Financing Update	2024-06-05	English
F-1/A Capital/Financing Update	2024-06-05	English
Telix Completes TLX250-CDx (Zircaix) BLA Submission 3 pages 161.2KB Regulatory Filings	2024-06-02	English
ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS 3 pages 170.9KB Regulatory Filings	2024-05-30	English
Update - Application for quotation of securities - TLX 6 pages 19.0KB Share Issue/Capital Change	2024-05-30	English
Regulatory Filings 2024 Regulatory Filings	2024-05-30	English
Response to ASX Query 6 pages 363.4KB Regulatory Filings	2024-05-27	English
Telix Submits NDA for New Prostate Cancer Imaging Agent 3 pages 155.0KB Regulatory Filings	2024-05-26	English
Telix Annual General Meeting - Chairman and CEO Addresses 6 pages 212.6KB AGM Information	2024-05-21	English
Telix Annual General Meeting - Presentation 18 pages 1.8MB AGM Information	2024-05-21	English
Telix Results of Annual General Meeting 3 pages 208.2KB Declaration of Voting Results & Voting Rights Announcements	2024-05-21	English
Becoming a substantial holder from MUFG 290 pages 6.4MB Major Shareholding Notification	2024-05-21	English
Telix Completes Proof-of-Concept Study for Alpha Therapy 3 pages 166.7KB Regulatory Filings	2024-05-20	English
Becoming a substantial holder 94 pages 2.2MB Major Shareholding Notification	2024-05-20	English
Becoming a substantial holder 94 pages 2.2MB Major Shareholding Notification	2024-05-20	English
Becoming a substantial holder from MS 357 pages 3.3MB Major Shareholding Notification	2024-05-20	English
Becoming a substantial holder 95 pages 2.9MB Major Shareholding Notification	2024-05-20	English
Becoming a substantial holder 5 pages 285.6KB Major Shareholding Notification	2024-05-20	English
Telix has Filed Registration Statement for Proposed US IPO 2 pages 138.7KB Capital/Financing Update	2024-05-19	English
Application for quotation of securities - TLX 6 pages 19.1KB Share Issue/Capital Change	2024-05-19	English
Cleansing Notice 1 page 117.5KB Regulatory Filings	2024-05-19	English
Notification regarding unquoted securities - TLX 7 pages 22.1KB Share Issue/Capital Change	2024-05-19	English
F-1 Capital/Financing Update	2024-05-17	English
Telix to File Registration Statement for Proposed US IPO 2 pages 129.4KB Capital/Financing Update	2024-05-16	English
Telix Reports Q1 2024 Financial Performance 2 pages 94.0KB Earnings Release Q1 2024	2024-05-16	English
Notification regarding unquoted securities - TLX 7 pages 23.9KB Share Issue/Capital Change	2024-05-14	English
Capital/Financing Update 2024 Capital/Financing Update	2024-05-09	English
Application for quotation of securities - TLX 7 pages 21.4KB Share Issue/Capital Change	2024-05-06	English
Cleansing Notice 1 page 149.4KB Regulatory Filings	2024-05-06	English
Telix Completes Acquisition of QSAM 3 pages 156.1KB Capital/Financing Update	2024-05-02	English
Pending Release of Shares from Voluntary Escrow 2 pages 147.6KB Regulatory Filings	2024-04-22	English
Telix Notice of AGM, Proxy Form and Online Guide 33 pages 4.0MB AGM Information	2024-04-21	English
Pending Release of Shares from Voluntary Escrow 2 pages 148.4KB Share Issue/Capital Change	2024-04-17	English
Telix Q1 2024 Revenue and Business Update 3 pages 174.4KB Interim / Quarterly Report Q1 2024	2024-04-16	English
Capital/Financing Update 2024 Capital/Financing Update	2024-04-15	English
TLX101-CDx (Pixclara) Granted FDA Fast Track Designation 4 pages 220.8KB Capital/Financing Update	2024-04-15	English
Telix Completes Acquisition of ARTMS 3 pages 175.7KB M&A Activity	2024-04-10	English
Application for quotation of securities - TLX 6 pages 18.8KB Share Issue/Capital Change	2024-04-10	English
Cleansing Notice 1 page 117.3KB Share Issue/Capital Change	2024-04-10	English
Notification of cessation of securities - TLX 5 pages 18.2KB Regulatory Filings	2024-04-09	English
Telix Completes Acquisition of IsoTherapeutics 2 pages 142.6KB Capital/Financing Update	2024-04-08	English
Application for quotation of securities - TLX 6 pages 18.8KB Share Issue/Capital Change	2024-04-08	English
Cleansing Notice 1 page 117.2KB Regulatory Filings	2024-04-08	English
Application for quotation of securities - TLX 7 pages 21.7KB Share Issue/Capital Change	2024-04-08	English
Cleansing Notice 1 page 150.2KB Regulatory Filings	2024-04-08	English
Telix General Meeting Chairman and CEO Addresses 7 pages 219.9KB AGM Information	2024-04-04	English
Telix General Meeting Presentation 16 pages 1.8MB Investor Presentation	2024-04-04	English
Telix General Meeting Results 3 pages 205.9KB Declaration of Voting Results & Voting Rights Announcements	2024-04-04	English
Notification regarding unquoted securities - TLX 6 pages 20.1KB Share Issue/Capital Change	2024-03-26	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-03-20	English
Cleansing Notice 1 page 148.8KB Regulatory Filings	2024-03-20	English
Capital/Financing Update 2024 Capital/Financing Update	2024-03-15	English
Appointment of Darren Patti to Group Chief Operating Officer 2 pages 142.4KB Board/Management Information	2024-03-11	English
Telix Notice of General Meeting, Proxy Form and Online Guide 40 pages 5.3MB Proxy Solicitation & Information Statement	2024-03-05	English
Telix to Acquire ARTMS (Isotope Production Platform) 4 pages 238.3KB M&A Activity	2024-03-04	English
Presentation to Accompany ARTMS Acquisition 12 pages 1.2MB Investor Presentation	2024-03-04	English
Proposed issue of securities - TLX 5 pages 18.3KB Capital/Financing Update	2024-03-04	English
Telix to Acquire IsoTherapeutics (US R&D and Manufacturing) 3 pages 159.8KB Capital/Financing Update	2024-02-26	English
Proposed issue of securities - TLX 5 pages 18.2KB Capital/Financing Update	2024-02-26	English
Appendix 4E and 2023 Annual Report 181 pages 21.8MB Regulatory Filings	2024-02-21	English
2023 Full Year Results Release 3 pages 132.3KB Annual Report FY 2023	2024-02-21	English
2023 Full Year Results Presentation 25 pages 1.5MB Annual Report FY 2023	2024-02-21	English
Appendix 4G and 2023 Corporate Governance Statement 31 pages 2.3MB Regulatory Filings	2024-02-21	English
Application for quotation of securities - TLX 6 pages 18.5KB Share Issue/Capital Change	2024-02-08	English
Cleansing Notice 1 page 149.0KB Regulatory Filings	2024-02-08	English
Telix Acquires QSAM and its Bone Cancer Targeting Platform 4 pages 244.4KB M&A Activity	2024-02-07	English
Presentation to Accompany QSAM Acquisition 12 pages 1.0MB Investor Presentation	2024-02-07	English
Proposed issue of securities - TLX 6 pages 22.4KB Capital/Financing Update	2024-02-07	English
Telix 2023 Full Year Results and Investor Webcast/Call 2 pages 146.0KB Report Publication Announcement	2024-02-06	English
Capital/Financing Update 2024 Capital/Financing Update	2024-02-02	English
Regulatory Filings 2024 Regulatory Filings	2024-01-25	English
Application for quotation of securities - TLX 6 pages 28.6KB Share Issue/Capital Change	2024-01-21	English
Cleansing Notice 1 page 150.0KB Share Issue/Capital Change	2024-01-21	English
Appendix 3Y Change in Director Interests - C Behrenbruch 4 pages 316.6KB Director's Dealing	2024-01-21	English
Notification of cessation of securities - TLX 4 pages 24.6KB Transaction in Own Shares	2024-01-07	English
Notification regarding unquoted securities - TLX 7 pages 32.0KB Share Issue/Capital Change	2024-01-07	English
JP Morgan Healthcare Conference and Trading Update 2 pages 191.3KB Investor Presentation	2024-01-07	English
JP Morgan Healthcare Conference Presentation 31 pages 2.4MB Investor Presentation	2024-01-07	English
Telix Plans U.S. Registered Public Offering and Listing 2 pages 127.9KB Capital/Financing Update	2024-01-04	English

Filings by year

2026 91 filings
2025 147 filings
2024 164 filings
2023 97 filings
2022 123 filings
2021 90 filings
2020 101 filings
2019 77 filings
2018 76 filings
2017 30 filings